The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 40 rounds in the feed, most often in AI.
A top venture and growth equity investment firm, Norwest has backed over 700 companies from AI pioneers to iconic retail giants and life-changing healthcare.
Venture capitalnorwest.comRounds from 2016-06-21 to 2026-10-21
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Vegafin Capital Pvt. A business lending startup | Funding round Verified against 4 of 14 sources | $106M | 2026-10-21 | [ PART ] |
SILA Properties The real estate development business of SILA | Growth Verified against 4 of 9 sources | $31.5M | 2026-10-14 |
| [ PART ] |
ICON Technology Iconbuild sells architectural design and construction services along with technology solutions for builders. | Series D Developing, 61 sources | $200M | ~ 2026-10-10 | [ PART ] |
Vitalize Vitalize provides an AI-powered operating system designed to optimize hospital staffing and scheduling, catering primarily to health systems. | Series A Verified against 1 of 19 sources | $31M | 2026-10-06 | [ PART ] |
Homeward A leader in cash-backed real estate financing solutions | Series D Verified against 4 of 31 sources | $120M | 2026-10-01 | [ PART ] |
Beltic Beltic provides infrastructure for secure, automated agent verification to facilitate trusted transactions. | Seed Verified against 1 of 15 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $7.3M | 2026-09-08 | [ LEAD ] |
Alice A security company focused on testing AI models and agents against adversarial attacks | Growth Verified against 1 of 7 sources | $140M | 2026-08-25 | [ PART ] |
Obsidian Security The leading platform securing non-human identities and AI agents across third-party applications | Series D Verified against 1 of 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $85M | 2026-08-04 | [ PART ] |
Zenity A provider of AI agent security and identity governance solutions | Series C Verified against 1 of 12 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $125M | 2026-08-03 | [ LEAD ] |
Generalist AI They create and train AI robots for various physical tasks. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $400M | 2026-06-04 | [ PART ] |
Ray Therapeutics Optogenetic therapies designed to restore functional vision for people with degenerative retinal diseases. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-04-21 | [ PART ] |
ORO Labs Orolabs sells procurement orchestration software that helps businesses automate and manage procurement processes. | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-03-12 | [ PART ] |
You.com Web search APIs providing real-time data for stocks, crypto, and other web content to developers and enterprises. | Series C Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-09-08 | [ PART ] |
Galvanize Therapeutics Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-09-03 | [ PART ] |
Rain Stablecoin payments platform for enterprise | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $58M | ~ 2025-08 | [ PART ] |
Avalyn Pharma Avalyn Pharma develops inhaled therapies targeting rare respiratory diseases, specifically pulmonary fibrosis and interstitial lung diseases, for patients and their care partners. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-07-23 | [ PART ] |
Classiq Quantum Computing Software | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2025-05-12 | [ PART ] |
Veza The Identity Security Platform | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $108M | 2025-04-28 | [ PART ] |
Rain Stablecoin payments platform for enterprise | Funding round Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $24.5M | 2025-03-24 | [ LEAD ] |
LlamaIndex LlamaIndex offers advanced document processing and extraction solutions powered by AI, catering primarily to businesses in industries like finance, insurance, and healthcare. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $19M | 2025-03-04 | [ LEAD ] |
Callio Therapeutics Dual-payload antibody-drug conjugates (ADCs) for cancer treatment. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $187M | 2025-03-03 | [ PART ] |
Ouro Medicines Ouro Medicines develops treatments for immune-mediated diseases, targeting patients with such conditions. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-01-10 | [ LEAD ] |
ORO Labs Orolabs sells procurement orchestration software that helps businesses automate and manage procurement processes. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $34M | 2023-11-01 | [ PART ] |
Avalyn Pharma Avalyn Pharma develops inhaled therapies targeting rare respiratory diseases, specifically pulmonary fibrosis and interstitial lung diseases, for patients and their care partners. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2023-09-27 | [ PART ] |
Ray Therapeutics Optogenetic therapies designed to restore functional vision for people with degenerative retinal diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2023-05-16 | [ PART ] |
ORO Labs Orolabs sells procurement orchestration software that helps businesses automate and manage procurement processes. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25M | 2022-11-03 | [ LEAD ] |
Harness Harness is a unified AI software delivery platform to manage the SDLC using purpose-built AI agents. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2022-04-26 | [ LEAD ] |
UPSIDE Foods UPSIDE Foods sells cultivated chicken products made from real chicken cells, appealing to consumers and restaurant partners | Series C Verified against 2 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $400M | 2022-04-21 | [ PART ] |
Obsidian Security The leading platform securing non-human identities and AI agents across third-party applications | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $90M | 2022-04-14 | [ LEAD ] |
Qventus AI-powered solutions for healthcare operations to improve patient flow, surgical growth, and administrative efficiency in hospitals. | Growth Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2022-02-28 | [ PART ] |
ICON Technology Iconbuild sells architectural design and construction services along with technology solutions for builders. | Series B Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $207M | 2021-08-24 | [ LEAD ] |
Faire Online Wholesale Marketplace for Retailers & Brands | Series E Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $170M | 2020-10-27 | [ PART ] |
Gong Gong sells AI-driven revenue intelligence software designed to enhance sales effectiveness and streamline customer interactions for businesses. | Series D+ Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2020-08-12 | [ PART ] |
Avalyn Pharma Avalyn Pharma develops inhaled therapies targeting rare respiratory diseases, specifically pulmonary fibrosis and interstitial lung diseases, for patients and their care partners. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $35.5M | 2020-04-27 | [ LEAD ] |
Gong Gong sells AI-driven revenue intelligence software designed to enhance sales effectiveness and streamline customer interactions for businesses. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65M | 2019-12-03 | [ PART ] |
Gong Gong sells AI-driven revenue intelligence software designed to enhance sales effectiveness and streamline customer interactions for businesses. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $40M | 2019-02-07 | [ PART ] |
Qventus AI-powered solutions for healthcare operations to improve patient flow, surgical growth, and administrative efficiency in hospitals. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2018-05-14 | [ PART ] |
Gong Gong sells AI-driven revenue intelligence software designed to enhance sales effectiveness and streamline customer interactions for businesses. | Series A Verified against 2 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $20M | 2017-07-12 | [ LEAD ] |
Swiggy Swiggy sells food delivery services from local restaurants to consumers in various cities. | Series E Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $80M | 2017-05-30 | [ PART ] |
Gong Gong sells AI-driven revenue intelligence software designed to enhance sales effectiveness and streamline customer interactions for businesses. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6M | 2016-06-21 | [ LEAD ] |